Artelo Biosciences files ATM offering of up to $6.53M in common stock

Artelo Biosciences registered a prospectus supplement for an at-the-market offering of up to $6.53 million in common shares through H.C. Wainwright & Co. The company is seeking to raise capital through a registered direct offering mechanism that allows flexibility in timing and pricing.